CTLA4 and neoplasm: These signatures indicate an immunologically active tumor, or “hot tumor,” and all patients with complete response or partial response in the anti-CTLA-4-resistant group had the “hot tumor” signature, although not all responders in the anti-CTLA-4-naïve group had the “hot tumor” signature.